Transforming Mental Health for Transgender and Gender-Diverse Young Adults Using Interventions to Drive Equity (TransHealthGUIDE): Protocol for a Digital Randomized Controlled Trial
JMIR Research Protocols · 2025
DOI: 10.2196/78619 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift JMIR Research Protocols, 2025. Verfasst von Sari L Reisner und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, MI, United States. Hauptthemen laut MEDLINE: Transgender Persons, Mental Health. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIMH NIH HHS, NIH HHS.
Abstract (Originalsprache)
Background
Transgender, nonbinary, and gender diverse (TGD) young adults face a disproportionately high mental health burden, including 2- to 4-fold increased risk of suicidality and depressive distress compared to their cisgender peers. Family and community support are protective factors that may mitigate these adverse outcomes, representing key targets for mental health interventions.
Objective
This randomized controlled trial (RCT) evaluates the effectiveness of TransHealthGUIDE, a novel digital, app-based education and support intervention aimed at reducing past 3-month suicidal ideation and past 2-week depressive distress among TGD young adults. Participants are randomized 1:1 to an immediate intervention arm or a 6-month deferred intervention arm (waitlist control).
Methods
From 2021 to 2024, a multidisciplinary team of academic and community partners conducted formative research and codeveloped a digital app containing 33 self-paced modules, communication, and interactive resources. The content is grounded in the Social Ecological Suicide Prevention Model and the Gender Minority Stress and Resilience Framework, designed to enhance family support and community connection for TGD young adults and their families. TGD young adults (ages 18-24 years) and their caregivers are prospectively enrolled and randomized in 10 US states (California, Connecticut, Illinois, Maryland, Massachusetts, New Jersey, New York, Oregon, Vermont, and Washington, DC). Participants complete self-reported surveys at baseline, 6 months, and 12 months, assessing sociodemographics, family support, community connection, suicidal ideation, depressive distress, and intervention acceptability. App usage and engagement are tracked via metadata. The target sample size is 500 TGD young adults, with 50% (n=250) identifying as people of color and 125 TGD young adult-caregiver dyads.
Results
TGD young adult and caregiver communities, including our community advisory board (CAB), have guided all aspects of the project: study design (eg, waitlist control), survey development (eg, self-reported rather than clinician-administered suicidality measures and inclusion of social justice activism as a form of support), intervention content (eg, text, infographics, interviews with TGD people and caregivers, and simulations), and digital app safety features (eg, a quick-exit button for privacy). Recruitment and study screening began on January 21, 2025. As of May 2, 2025, a total of 149 individuals completed a study screener, with 132 (88.6%) of 149 found eligible. Enrollment visits began on April 23, 2025. As of May 2, 2025, five TGD young adults have been enrolled. Ongoing engagement with the CAB will inform iterative improvements throughout the trial.
Conclusions
Scalable, app-based interventions tailored to meet the needs of TGD young people hold promise for population-level mental health impact. This RCT—targeting suicidality and depressive distress via education and support for both TGD young adults and their caregivers—addresses a critical gap in mental health interventions for this underserved population. Trial Registration ClinicalTrials.gov NCT06177600; https://clinicaltrials.gov/study/NCT06177600 International Registered Report Identifier (IRRID) DERR1-10.2196/78619
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Epidemiology, University of Michigan School of Public Health, Ann Arbor, MI, United States.
- Health, Behavior and Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States.
- Queery Research Consulting, Glen Burnie, MD, United States.
- Department of Psychiatry, Massachusetts General Hospital, Boston, MA, United States.
- Department of Psychiatry, Harvard Medical School, Boston, MA, United States.
- Division of Adolescent/Young Adult Medicine, Boston Children's Hospital, Boston, MA, United States.
ORCID-Profile: Sari L Reisner, S Wilson Cole, Alex S Keuroghlian, Sabra L Katz-Wise, Cassandra Morrow, Kaiden Kane, Caitlynn Feng, Rena Xu
Förderung
- NIMH NIH HHS
- NIH HHS
Zitieren
APA
Reisner, S. L., Cole, S. W., Keuroghlian, A. S., Katz-Wise, S. L., Morrow, C., Kane, K., Feng, C., & Xu, R. (2025). Transforming Mental Health for Transgender and Gender-Diverse Young Adults Using Interventions to Drive Equity (TransHealthGUIDE): Protocol for a Digital Randomized Controlled Trial. JMIR Research Protocols. https://doi.org/10.2196/78619
Vancouver
Reisner SL, Cole SW, Keuroghlian AS, Katz-Wise SL, Morrow C, Kane K, et al. Transforming Mental Health for Transgender and Gender-Diverse Young Adults Using Interventions to Drive Equity (TransHealthGUIDE): Protocol for a Digital Randomized Controlled Trial. JMIR Research Protocols. 2025. doi:10.2196/78619
BibTeX
@article{Reisner2025,
author = {Reisner, Sari L and Cole, S Wilson and Keuroghlian, Alex S and Katz-Wise, Sabra L and Morrow, Cassandra and Kane, Kaiden and Feng, Caitlynn and Xu, Rena},
title = {Transforming Mental Health for Transgender and Gender-Diverse Young Adults Using Interventions to Drive Equity (TransHealthGUIDE): Protocol for a Digital Randomized Controlled Trial},
journal = {JMIR Research Protocols},
year = {2025},
doi = {10.2196/78619}
}
EUVIMED